341 related articles for article (PubMed ID: 28579826)
1. Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents.
Khalafalla FG; Khan MW
Cancer Growth Metastasis; 2017; 10():1179064417709287. PubMed ID: 28579826
[TBL] [Abstract][Full Text] [Related]
2. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance.
Palamaris K; Felekouras E; Sakellariou S
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771695
[TBL] [Abstract][Full Text] [Related]
3. Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma.
Hu X; Chen W
World J Clin Cases; 2021 Jul; 9(19):4998-5006. PubMed ID: 34307550
[TBL] [Abstract][Full Text] [Related]
4. Role of epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma: is tumor budding the missing link?
Karamitopoulou E
Front Oncol; 2013 Sep; 3():221. PubMed ID: 24062980
[TBL] [Abstract][Full Text] [Related]
5. The Role of
Racu ML; Lebrun L; Schiavo AA; Van Campenhout C; De Clercq S; Absil L; Minguijon Perez E; Maris C; Decaestecker C; Salmon I; D'Haene N
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205719
[TBL] [Abstract][Full Text] [Related]
6. Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities.
Dardare J; Witz A; Merlin JL; Bochnakian A; Toussaint P; Gilson P; Harlé A
Pharmaceuticals (Basel); 2021 Jul; 14(8):. PubMed ID: 34451837
[TBL] [Abstract][Full Text] [Related]
7. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
8. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma.
Träger MM; Dhayat SA
Int J Cancer; 2017 Jul; 141(1):24-32. PubMed ID: 28133736
[TBL] [Abstract][Full Text] [Related]
10. Snail-Overexpression Induces Epithelial-mesenchymal Transition and Metabolic Reprogramming in Human Pancreatic Ductal Adenocarcinoma and Non-tumorigenic Ductal Cells.
Liu M; Hancock SE; Sultani G; Wilkins BP; Ding E; Osborne B; Quek LE; Turner N
J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31181802
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of nucleoprotein AHNAK is associated with poor outcome of pancreatic ductal adenocarcinoma prognosis via mediating epithelial-mesenchymal transition.
Zhang Z; Liu X; Huang R; Liu X; Liang Z; Liu T
J Cancer; 2019; 10(16):3860-3870. PubMed ID: 31333803
[TBL] [Abstract][Full Text] [Related]
12. Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer.
Karamitopoulou E
Front Oncol; 2012; 2():209. PubMed ID: 23316479
[TBL] [Abstract][Full Text] [Related]
13. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F; Li W; Li C; Gao Z; Guo K; Song S
Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
[TBL] [Abstract][Full Text] [Related]
14. SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression.
Carrasco-Garcia E; Lopez L; Moncho-Amor V; Carazo F; Aldaz P; Collado M; Bell D; Gaafar A; Karamitopoulou E; Tzankov A; Hidalgo M; Rubio Á; Serrano M; Lawrie CH; Lovell-Badge R; Matheu A
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205666
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition induction is associated with augmented glucose uptake and lactate production in pancreatic ductal adenocarcinoma.
Liu M; Quek LE; Sultani G; Turner N
Cancer Metab; 2016; 4():19. PubMed ID: 27777765
[TBL] [Abstract][Full Text] [Related]
16. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
Yuan Q; Zhang Y; Feng L; Jiang Y
J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
[TBL] [Abstract][Full Text] [Related]
17. MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma.
Hu J; Li L; Chen H; Zhang G; Liu H; Kong R; Chen H; Wang Y; Li Y; Tian F; Lv X; Li G; Sun B
Cell Death Dis; 2018 Jul; 9(8):807. PubMed ID: 30042387
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.
Wang S; Huang S; Sun YL
Biomed Res Int; 2017; 2017():2646148. PubMed ID: 29379795
[TBL] [Abstract][Full Text] [Related]
19. HMGN5 promotes proliferation and invasion via the activation of Wnt/β-catenin signaling pathway in pancreatic ductal adenocarcinoma.
Zhao J; Wang Y; Wu X
Oncol Lett; 2018 Sep; 16(3):4013-4019. PubMed ID: 30128022
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
